Financial companies are leading the rush to file patents for tools and products based on blockchain, the ledger technology underlying bitcoin, and a wave of litigation could be on the horizon. Here is what intellectual property attorneys need to know about the patent landscape for the increasingly popular tech.
Santa Clara, Calif.-based Macrovision Corp. sued 321 Studios over its DVD copying system, claiming the software infringes its patented copy protection technology and violates the Digital Millennium Copyright Act.
Digital video recorder company TiVo has filed a patent infringement suit against EchoStar Communications, a satellite TV service provider, over set-top boxes that record television programming onto a built-in hard drive.
Boston intellectual property boutique Lowrie, Lando and Anastasi, LLP promoted Robert A. Skrivanek, Jr., to partner and hired Keith F. Noe as of counsel.
Seasoned international trade and intellectual property attorney Charles Schill has joined national law firm Steptoe & Johnson LLP's Washington office as a partner.
A U.S. District Court judge in Manhattan invalidated Purdue Pharma’s patents protecting the controversial and widely abused pain killer Oxycontin, clearing the way for drug maker Endo Pharmaceuticals to sell a generic version.
Japan’s Asics Corp. has filed a lawsuit in the U.S. District Court in Central California against discount shoe seller Payless ShoeSource Inc. for trademark infringement, unfair competition, trademark dilution and false advertising.
Steven H. Bazerman, who co-founded the intellectual property law firm Bazerman & Drangel and was instrumental in developing the current notion of trade dress, has passed away in New York.
In a sign that the U.S. music industry’s aggressive legal strategy is working, online music piracy plummeted in the second half of 2003, a new survey shows.
GlaxoSmithKline has settled a lawsuit against Synthon Pharmaceuticals, clearing the way for generic drug maker to immediately start selling Pexeva, its competitor to the U.K. pharmaceutical giant’s antidepressant Paxil.
National law firm acquires San Francisco’s media specialist Steinhart & Falconer and looks for other targets for planned expansion of IP practice.
A French government agency for atomic energy has filed a patent lawsuit over flat-screen displays against Chi Mei Optoelectronics Corp, Taiwan's second-largest maker of computer display screens.
The U.S. Court of Appeals for the Ninth Circuit dismissed Visa International’s motion for an injunction against the use of the domain name eVisa, citing a recent case before the Supreme Court.
The U.S. District Court for the Northern District of California has ruled in favor of Allergan and Syntex in their patent infringement suit against Canadian generic drug maker Apotex and Novex Pharma over Allergan's non-steroidal anti-inflammatory drug Acular.
Mid-Atlantic law firm Eckert Seamans Cherin and Mellott expects to expand its Pittsburgh intellectual property practice group after winning aluminum giant Alcoa’s IP business last year.
The act signed into law last month modifies the U.S. approval process for generic drugs in several important ways, intellectual property attorneys say.
California-based maker of blood testing products will pay $7 million to Roche Diagnostics to settle litigation over patents related to measuring HDL cholesterol.
International law firm Reed Smith has acquired Shanks & Herbert, a seven-year-old intellectual property firm that specializes in chemical, pharmaceutical and software intellectual property issues.
Glaxo sues over Dr. Reddy's ANDA filing for generic version of migraine drug with global sales of $1.2 billion last year.
Legal action follows Shire's lawsuit against Barr Laboratories over plans to market generic version of top-selling drug for attention deficit hyperactivity disorder in children.
The Court of Appeals for the Federal Circuit upholds a preliminary injunction barring India’s Ranbaxy Pharmaceuticals from marketing a generic version of Pfizer's Vantin antibiotic.